JACOBSEN JOHN R. (CSO) sold 11.3% of their position (18.75K shares) of DICE THERAPEUTICS, INC. on the open market
Open‑market sale worth $572.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/2/2023ACC: 0001209191-23-034096
Officer· CSO
Since Sep 2021
-18.75K
Net shares
Net seller
$572.4K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
18.75K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−14.31K
Price / share
$30.31
Trade value
$433.65K
% of position
8.6%
6/1/2023
166.25K→151.94K
Common Stock
Direct
Shares
−4.44K
Price / share
$31.24
Trade value
$138.80K
% of position
2.9%
6/1/2023
151.94K→147.50K
Total
Net shares
−18.75K
Net value
-$572.44K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/1/2023 | S · Sale | −14.31K | $30.31 | $433.65K | 8.6% | 166.25K | 151.94K |
| Common Stock Direct | 6/1/2023 | S · Sale | −4.44K | $31.24 | $138.80K | 2.9% | 151.94K | 147.50K |
| Total | −18.75K | -$572.44K | ||||||
Derivative Transactions0
No derivative transactions reported